Fixed dose combination Ciprofloxacin/Celecoxib

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
2	筋萎縮性側索硬化症	2

2. 筋萎縮性側索硬化症

臨床試験数 : 645 / 薬物数 : 589 - (DrugBank : 163) / 標的遺伝子数 : 150 - 標的パスウェイ数 : 225

trials per page:

Showing 1 to 2 of 2 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04090684 (ClinicalTrials.gov)	December 9, 2019	29/8/2019	Ciprofloxacin/Celecoxib Combination in Patients With ALS	Open Label, Off Label Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of Ciprofl ...	ALS (Amyotrophic Lateral Sclerosis)	Drug: Fixed dose combination Ciprofloxacin/Celecoxib	NeuroSense Therapeutics Ltd.	NULL	Completed	18 Years	75 Years	All	10	Phase 1	United States
2	NCT04165850 (ClinicalTrials.gov)	November 25, 2019	13/11/2019	Open Label Study to Evaluate Ciprofloxacin/Celecoxib Combination in Patients With ALS	Open Label Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of Ciprofloxacin/Cele ...	Amyotrophic Lateral Sclerosis;ALS	Drug: Fixed dose combination Ciprofloxacin/Celecoxib	NeuroSense Therapeutics Ltd.	NULL	Completed	18 Years	75 Years	All	16	Phase 2	Israel

First Previous1Next Last